series-c-plus
Stage
1
Investors
About
Iantrek develops medical technologies for micro-interventional ophthalmic surgery to enhance aqueous outflow in glaucoma treatment, utilizing bio-interventional and micro-interventional devices targeting the uveoscleral pathway and canaloplasty procedures.
Explore Iantrek's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.